Pancreatic Cancer Research

ResearcherMedical University of South CarolinaNo recent work listed

Elizabeth C. Little

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5083994081. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper

Papers 4

  1. Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer. Co-author DOI 10.3892/ol.2017.5956↗
  2. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Co-author DOI 10.1038/oncsis.2015.45↗
  3. Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Co-author DOI 10.1038/cgt.2013.9↗
  4. Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. Co-author DOI 10.1016/j.jss.2011.10.025↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David J. Cole · 3 shared papers, 2012–2016 · strength 0.14
  2. Ernest Ramsay Camp · 3 shared papers, 2012–2016 · strength 0.14
  3. Dennis K. Watson · 3 shared papers, 2012–2016 · strength 0.14
  4. Deborah Lang · 1 shared paper, 2017 · strength 0.09
  5. Paul J. Grippo · 1 shared paper, 2017 · strength 0.09
  6. Ravi Salgia · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.